Advantech Capital
Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.
Business Model:
Revenue: $1.6M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Advantech Capital Information
Geographic Data
Address: One Exchange Square,8 Connaught Place
City: Central
State: other
Zip:
Country: HK
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2016 | Rokid | Series B | 50M |
| 7/2018 | Sinovac Biotech | Post-IPO Equity | 86.7M |
| 11/2016 | Petuum | Series A | 15M |
| 3/2018 | Qutoutiao | Series B | 200M |
| 10/2021 | Boan Biotech | Series B | 18.8M |
| 3/2022 | ELITE Technology | Series C | - |
| 8/2018 | Ideanomics | Post-IPO Equity | 12M |
| 4/2016 | Tongdun Technology | Series B | 32M |
| 12/2021 | Innoforce Pharmaceuticals | Series A | 0 |
| 1/2018 | DTRM Biopharma | Series A | 60M |
| 11/2018 | Alphamab Oncology | Series A | 0 |
| 3/2019 | InventisBio | Series C | 70M |
| 7/2017 | SenseTime | Series B | 0 |
| 6/2021 | Stemirna | Venture Round | 0 |
| 10/2017 | Petuum | Series B | 93M |
| 1/2016 | Zai Lab | Series B | 106.2M |
| 6/2021 | Onconano Medicine | Series B | 0 |
| 1/2022 | CureGenetics | Series B | 0 |
| 1/2019 | Connect Biopharmaceuticals | Series B | 55M |
| 8/2018 | Harbour Biomed | Series B | 0 |
| 1/2019 | AutoAI | Venture Round | 0 |
| 12/2016 | Harbour Biomed | Series A | 50M |
| 5/2019 | Alphamab Oncology | Series B | 60M |
| 1/2018 | KBP Biosciences | Series A | 0 |
| 10/2018 | Xiaozhu | Series F | 300M |
| 12/2018 | Emotibot Technologies | Series B | 0 |
| 3/2020 | Harbour Biomed | Series B | 75M |
| 9/2020 | InventisBio | Series D | 0 |
| 7/2018 | Zhihu | Series E | 270M |
| 3/2019 | Mojo Vision | Series B | 0 |
| 11/2021 | Zhimeng Biopharma | Series B | 0 |
| 1/2022 | Mojo Vision | Series B | 0 |
| 1/2018 | Harbour Biomed | Series A | - |
| 6/2019 | Kaiyi Technology | Series A | 14.5M |
| 11/2021 | Ablaze Pharmaceuticals | Series A | 0 |
| 6/2018 | Nanos Medical | Series B | - |
| 6/2021 | Zhuanzhuan | Series D | 100M |
| 3/2022 | ELITE Technology | Series C | - |
| 1/2022 | CureGenetics | Series B | 0 |
| 1/2022 | Mojo Vision | Series B | 0 |
| 12/2021 | Innoforce Pharmaceuticals | Series A | 0 |
| 11/2021 | Ablaze Pharmaceuticals | Series A | 0 |
| 11/2021 | Zhimeng Biopharma | Series B | 0 |
| 10/2021 | Boan Biotech | Series B | 0 |
| 6/2021 | Zhuanzhuan | Series D | 0 |
| 6/2021 | Onconano Medicine | Series B | 0 |
| 6/2021 | Stemirna | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
